Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Logo of oncotargetLink to Publisher's site
PMC full text:

Table 1

Association between plasma miR-224 level and clinicopathological characteristics in patients with HCC
VariablesnPlasma miR-224
MedianP valuea
Total8719.69
Gendermale5917.020.1396
female2823.60
Age (years old)< 703217.230.3963
70 ≤5519.69
BMIb< 256020.270.1364
25 ≤2714.99
DMcPositive2517.220.2225
Negative6219.69
Viral infection (HBV or HCV)Positive5221.900.1207
Negative3516.82
Liver cirrhosisPositive2820.460.3848
Negative5917.32
Pathological TypeWelld2316.820.3519
Moderately or poorlye6419.85
Vascular invasionPositive1416.900.4499
Negative7319.69
Tumor size (mm)<203514.990.0005
20 ≤5224.02
pStage (LCSGJf)I3015.360.0382
II-IV5720.34
pStage (TNM: AJCC/UICCg)I6219.850.4464
II-IV2517.16
RecurrencePositive2925.220.0027
Negative5816.21
aMann-Whitney U-test, NOTE : Significant values are indicated in bold;
bBody mass index;
cdiabetes mellitus;
dwell-differentiated hepatocellular carcinoma;
emoderately or poorly differentiated hepatocellular carcinoma;
fLiver Cancer Study Group of Japan;
gAmerican Joint Committee on Cancer/International Union Against Cancer